Published Clinical Study Finds WaterWorks Both Safe And More Effective Than Over-The-Counter Douching Products

Share Article

Prospective, multicenter, double-blind randomized study published in The Journal of Lower Genital Tract Disease concludes WaterWorks more effectively reduces perceived vaginal odor

A peer-reviewed, published clinical study proves that WaterWorks is safe and more effective than over-the-counter douching products in eliminating or reducing vaginal odor. The study entitled “Douching for Perceived Vaginal Odor with No Infectious Cause of Vaginitis: A Randomized Controlled Trial” has been approved and accepted for publication in The Journal of Lower Genital Tract Disease.

The study among 96 women demonstrated the safety and effectiveness of the medical-grade stainless steel WaterWorks feminine cleansing device for treating abnormal vaginal odor as compared to a commercially-available over-the-counter plastic douching device. Use of WaterWorks resulted in a significant reduction of vaginal odor after four (4) weeks. The success rate of odor reduction was 78% for the WaterWorks group and 38.5% for the control group, prompting the study authors to conclude, “The Water Works device with medical-grade stainless steel nozzle, when used with water, was significantly better than the commercially available over-the-counter plastic douching device in reducing or eliminating self-reported vaginal odor.”

Previous studies have shown that traditional methods of douching may be associated with increased vaginal infections, Pelvic Inflammatory Disease (PID) and other adverse effects. This study found that WaterWorks’ significant reduction of vaginal odor came without any alteration of vaginal flora. The authors noted, “We found that douching using water is valuable for the treatment of vaginal odor and much appreciated by symptomatic women and does not seem to interfere with maintenance of a normal vaginal ecosystem.”

“The WaterWorks System is easy to use and its beneficial effects occur rapidly”, said Chun Lim Abbott, CEO of Abbott Research Group, Inc, manufacturer of WaterWorks. “Unlike many over-the-counter douches which may contain harsh chemicals, WaterWorks uses only tap water. WaterWorks is safe to use, has no adverse effects, has not been associated with increased vaginal infections and actually restores the vaginal eco-system. What a perfect choice for women looking for a natural solution to their vaginal odor problems or simply to feel more fresh and clean.”

The study was conducted by Jack Sobel, MD, Sarmina Hassan, MBBS, Ashwin Chatwani, MD, Herman Brovender, MD, Richard Zane, MD, and Thomas Valaoras, MD.

The Journal of Lower Genital Tract Disease, is the peer-reviewed official publication of the American Society for Colposcopy and Cervical Pathology, the Australian Society for Colposcopy and Cervical Pathology, the Society of Canadian Colposcopists, the International Federation of Cervical Pathology and Colposcopy, Asociación Española de Patología Cervical y Colposcopia, Portuguese Sections of Colposcopy and Cervico Vulvo Vaginal Pathology, and the International Society for the Study of Vulvovaginal Disease.

About WaterWorks:
WaterWorks is the only FDA cleared product clinically proven to eliminate or reduce feminine odor safely and effectively. WaterWorks’ medical grade, lightweight stainless steel nozzle and low-pressure water combination is designed for easy, reusable use in the shower as part of a daily routine. A custom-designed water container is attached to the device via a latex-free hose and filled with 32 ounces of ordinary tap water. The water container and hose are biocompatible with the delicate vaginal tissue, as proven through extensive laboratory testing. The water container is placed at eye level so the natural gravity flow of water gently washes the vagina. Although results are typically expected within two weeks, users often notice results within one to three uses. For additional product details regarding WaterWorks, visit http://www.WaterWorksHealth.com

About Abbott Research Group, Inc.:
Abbott Research Group, Inc., doing business as ARG, is headquartered in RIDC Park in O’Hara Township, a suburb of Pittsburgh, PA. In 1999, ARG was formed to research and develop personal healthcare products, completely by self -funded medical research. ARG is initially focusing on women’s health issues, with intellectual property including four (4) US Patents and two (2) US Patents pending. For additional information regarding Abbott Research Group, Inc., visit http://www.AbbottResearchGroup.com

About the Journal of Lower Genital Tract Disease:
The Journal of Lower Genital Tract Disease, the official publication of the American Society for Colposcopy and Cervical Pathology, the Australian Society for Colposcopy and Cervical Pathology, the Society of Canadian Colposcopists, the International Federation of Cervical Pathology and Colposcopy, Asociación Española de Patología Cervical y Colposcopia, Portuguese Sections of Colposcopy and Cervico Vulvo Vaginal Pathology, and the International Society for the Study of Vulvovaginal Disease, is the source for the latest science in the field of diagnosis, etiology, and the therapy of pathologic conditions of the cervix, vagina, vulva, and anus. The Journal is a peer-reviewed publication for the exchange of information among interested health care providers from many different disciplines including pathology, cytology, cytogenetics, gynecologic oncology, endocrinology, preventive medicine, basic science, and clinical medicine. The editor-in-chief is Edward J. Wilkinson, MD and executive editor is Thomas M. Julian, MD.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chun Lim Abbott
Visit website